High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial

Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
doi: https://doi.org/10.1101/2021.09.15.21263597

Data Availability

De-identified data will be available upon request

Back to top
Posted September 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
medRxiv 2021.09.15.21263597; doi: https://doi.org/10.1101/2021.09.15.21263597
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area